1. Clinical management of patients with COVID-19 “live” clinical guidelines. (2022). Kyiv: Ministerstvo okhorony zdorovia Ukrainy, Derzhavnyi ekspertnyi tsentr ministerstva okhorony zdorovia Ukrainy, Derzhavna naukova ustanova «Naukovo-praktychnyi tsentr profilaktychnoi i klinichnoi medytsyny» Derzhavnoho upravlinnia spravamy. URL: https://www.dec.gov.ua/wp-content/uploads/2022/08/2022_08_24_kn_covid-19_.pdf [in Ukrainian].
2. World Health Organization (2020). Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19. Retrieved from: https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19.
3. Riphagen, S., Gomez, X., Gonzalez-Martinez, C., Wilkinson, N., & Theocharis, P. (2020). Hyperinflammatory shock in children during COVID-19 pandemic. Lancet (London, England), 395(10237), 1607–1608. https://doi.org/10.1016/S0140-6736(20)31094-1
4. Royal College of Paediatrics and Child Health (2020). Leading paediatricians publish case definition for illness affecting children during COVID-19. Retrieved from: https://www.rcpch.ac.uk/sites/default/files/2020-05/COVID-19-Paediatric-multisystem-%20inflammatory%20syndrome-20200501.pdf.
5. Potekhina T. (2020). Kawasaki-like symptoms in children with COVID-19: pediatric multisystem inflammatory syndrome. Dytiachyi likar – Children’s doctor, 2 (71), 21-24. URL: https://d-l.com.ua/en/archive/2020/2%2871%29/pages-21-24/kavasaki-podibni-simptomi-v-ditey-z-covid-pediatrichniy-multisistemniy-zapalniy-sindrom [in Ukrainian].